Company Filing History:
Years Active: 2015
Title: Tine Van Bergen: Innovator in Trabeculectomy Surgery
Introduction
Tine Van Bergen is a notable inventor based in Hoogstraten, Belgium. He has made significant contributions to the field of ophthalmology, particularly in improving surgical outcomes for patients undergoing trabeculectomy.
Latest Patents
Tine Van Bergen holds a patent for "Improving trabeculectomy outcome by administering an anti-placental growth factor antibody." This invention focuses on enhancing the results of trabeculectomy surgery by extending the lifetime of the sclera-corneal drainage channel created during the procedure. The improvement is achieved through the post-surgical administration of an anti-PlGF antibody or its fragment.
Career Highlights
Tine is associated with Thrombogenics NV, a company dedicated to developing innovative treatments for eye diseases. His work has been instrumental in advancing surgical techniques and improving patient care in ophthalmology.
Collaborations
Tine collaborates with esteemed colleagues, including Bart Jonckx and Ingeborg Stalmans, who contribute to the research and development efforts at Thrombogenics NV.
Conclusion
Tine Van Bergen's innovative approach to trabeculectomy surgery exemplifies the impact of research and development in medical science. His contributions continue to enhance surgical outcomes and improve the quality of life for patients.